DexCom, Inc. (NASDAQ:DXCM – Get Rating) Director Steven Robert Pacelli sold 412 shares of the company’s stock in a transaction on Friday, June 23rd. The shares were sold at an average price of $125.92, for a total value of $51,879.04. Following the completion of the sale, the director now owns 131,862 shares in the company, […]
Revolve Wealth Partners LLC reduced its position in DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 7.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,328 shares of the medical device company’s stock after selling 178 shares during the […]
DexCom, Inc. (NASDAQ:DXCM – Get Rating) CFO Jereme M. Sylvain sold 2,400 shares of the firm’s stock in a transaction on Monday, May 22nd. The stock was sold at an average price of $117.58, for a total value of $282,192.00. Following the transaction, the chief financial officer now owns 74,711 shares in the company, valued […]
Sit Investment Associates Inc. lifted its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 3.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 137,126 shares of the medical device company’s stock after purchasing an additional 4,066 shares […]
Vanguard Personalized Indexing Management LLC grew its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 44.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 31,513 shares of the medical device company’s stock after buying an additional 9,692 shares during the period. […]